Relationship between Oral Metformin Use and Age-Related Macular Degeneration
- PMID: 32525055
- PMCID: PMC7609465
- DOI: 10.1016/j.oret.2020.06.003
Relationship between Oral Metformin Use and Age-Related Macular Degeneration
Abstract
In a cross-sectional retrospective study of 3120 diabetic patients aged ≥ 60 years, those taking metformin were less likely to have age-related macular degeneration compared with those not taking the drug (OR 0.70, 95%CI 0.55-0.88).
Conflict of interest statement
Conflict of interest: None.
References
-
- Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55(6):1577–1596. - PubMed
-
- Zhang C-S, Li M, Ma T, et al. Metformin Activates AMPK through the Lysosomal Pathway. Cell Metab. 2016;24(4):521–522. - PubMed
-
- Dowling RJO, Zakikhani M, Fantus IG, Pollak M, Sonenberg N. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res. 2007;67(22):10804–10812. - PubMed
-
- Poh S, Mohamed Abdul RBB, Lamoureux EL, Wong TY, Sabanayagam C. Metabolic syndrome and eye diseases. Diabetes Res Clin Pract. 2016;113:86–100. - PubMed
